MedPath

Improving the response to high intensity interval training through the ingestion of a daily prebiotic fibre.

Not Applicable
Completed
Conditions
Cardiorespiratory fitness
Diet and Nutrition - Other diet and nutrition disorders
Cardiovascular - Normal development and function of the cardiovascular system
Registration Number
ACTRN12618000501246
Lead Sponsor
niversity of Queensland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

•Inactive adults aged between 18 and 50 years
•Less than 60 minutes of structured exercise each week
•Signed consent form

Exclusion Criteria

•Antibiotic use 6 months prior to intervention or antibiotic use during intervention.
•Pre- or-probiotic use within four weeks of participating in study
•Pregnancy, chronic infections, auto-immune diseases and intestinal chronic conditions (e.g. IBS, Chrohn’s disease, ulcerative colitis, coeliac disease).
•Existing cardiac conditions
•Recent surgery or orthopaedic conditions that prevents treadmill walking/running

•Diabetes
•Allergies to inulin (chicory root) or fructans
•Allergies to maltodextrin and other polysaccharides
•Allergies to soy, milk and egg (there maybe traces of these in maltodextrin)
•Greater than 60 minutes of exercise per week within four weeks of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
An incremental treadmill test to exhaustion will be completed to ascertain VO2peak. This test will be the Bruce Ramp protocol. This test will be assessed via indirect calorimetry and will determine VO2peak directly.[Pre and post 6 week exercise intervention (8 weeks post randomisation).];A panel of genetic variants that are correlated with VO2peak training reponse will be identified from a saliva sample collected via an Oragene collection kit. Saliva samples will be sent to the Translational Research Institute (TRI) for DNA extraction and GWAS analysis. [Baseline]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath